PEG 3350
PEG 3350 is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children
Polyethylene Glycol Safety in Children
A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation
Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity
Clinical Trials (7)
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children
Polyethylene Glycol Safety in Children
A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation
Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity
Comparison Trial of Enema vs. PEG 3350 for Constipation
Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7